Lessons Learned From Characterizing Long <scp>COVID</scp> Among US Medicare Beneficiaries

In this large study of 32 million Medicare beneficiaries, we found approximately 194 000 post-COVID condition diagnoses. Post-COVID condition diagnosis rate was higher among nursing home residents, highlighting the substantial burden of COVID-19 in this vulnerable population. Community-dwelling beneficiaries were less likely to seek medical care for COVID-19 events than nursing home residents, which may suggest differences in COVID-19 severity and respiratory disease detection between these populations. Long COVID risk after COVID-19 infection may be similar across demographic groups.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2025-01-22
DOI
https://doi.org/10.1002/pds.70101
Citations
1
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries

Yun Lu, Mikhail Menis, Héctor S. Izurieta, Michael Wernecke et al.
1 citations
Pharmacoepidemiology and Drug Safety
Long-Term Effects of COVID-19
1.39
article

Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries

Yun Lu, Mikhail Menis, Héctor S. Izurieta, Michael Wernecke, Yoganand Chillarige, Arnstein Lindaas, Whitney R. Steele, Richard A. Forshee, Myrna Cozen, Xiangyu Shi, Jeffrey A. Kelman
article en
1 citations

Abstract

In this large study of 32 million Medicare beneficiaries, we found approximately 194 000 post-COVID condition diagnoses. Post-COVID condition diagnosis rate was higher among nursing home residents, highlighting the substantial burden of COVID-19 in this vulnerable population. Community-dwelling beneficiaries were less likely to seek medical care for COVID-19 events than nursing home residents, which may suggest differences in COVID-19 severity and respiratory disease detection between these populations. Long COVID risk after COVID-19 infection may be similar across demographic groups.

Pharmacoepidemiology and Drug SafetyVol. 34(2)
Center for Biologics Evaluation and Research (US), Acumen (United States) (US), Feed Control (Norway) (NO), Centers for Medicare and Medicaid Services (US)
U.S. Food and Drug Administration, Food and Drug Administration
No poverty
Openalex Percentile: Top 24%
Long-Term Effects of COVID-19
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lessons Learned From Characterizing Long <scp>COVID</scp> Among US Medicare Beneficiaries — Yun Lu, Mikhail Menis, et al. · Pharmacoepidemiology and Drug Safety (2025) | TGRS Research Map | TGRS